HOE 140 Chemical Properties

Density 

1.60±0.1 g/cm3(Predicted)

storage temp. 

Sealed in dry,2-8°C

solubility 

Water:100.0(Max Conc. mg/mL);76.66(Max Conc. mM)

pka

3.60±0.21(Predicted)

form 

powder

color 

white

Water Solubility 

Soluble to 1 mg/ml in water

Sequence

H-D-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-D-Tic-Oic-Arg-OH

InChIKey

QASONHYHOCRAHL-DOMVFXHKSA-N

CAS DataBase Reference

130308-48-4

Safety Information

WGK Germany 

3

MSDS

• Language:English Provider:SigmaAldrich

HOE 140 Usage And Synthesis

Description

Hoe 140 (D-Arg-[Hyp3, Thi5, D-Tic7, Oic8]-bradykinin), on bradykinin- and platelet-activating factor (PAF)-induced bronchoconstriction and airway microvascular leakage in anesthetized guinea pigs. Hoe 140 is highly potent and long-acting in inhibiting BK-induced hypotensive responses in the rat. Four hours after s.c. administration of 20nmol kg-1, inhibition still amounted to 60% whereas the effect of 200nmol kg-1 of d-Arg-[Hyp2, Thi5,8, d-Phe7]BK was not significant[1-2].

Uses

Antagonist (bradykinin).

Definition

ChEBI: A ten-membered synthetic oligopeptide consisting of D-Arg, Arg, Pro, Hyp, Gly, Thi, Ser, D-Tic, Oic, and Arg residues joined in sequrence. A bradykinin receptor antagonist used as its acetate salt for the treatment of acut attacks of hereditary angioedema in adult patients.

brand name

Metastat (CollaGenex).

Biological Activity

Hoe 140 is highly potent and long-acting in inhibiting BK-induced hypotensive responses in the rat. Four hours after s.c. administration of 20 nmol kg^?1, inhibition still amounted to 60%, whereas the effect of 200 nmol kg^?1 of d-Arg—[Hyp2, Thi5,8, d-Phe7]BK was not significant. In receptor binding studies in guinea-pig ileum preparations, Hoe 140 showed an IC50 of 1.07 × 10?9mol l^?1 and a KI value of 7.98 × 10?10 mol l^?1.

storage

Store at -20°C

References

[1] K. Wirth. “Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies.” British Journal of Pharmacology 102 3 (1991): 774–777.
[2] T Sakamoto. “Effect of Hoe 140, a new bradykinin receptor antagonist, on bradykinin- and platelet-activating factor-induced bronchoconstriction and airway microvascular leakage in guinea pig.” European journal of pharmacology 213 3 (1992): 367–73.

HOE 140(130308-48-4)Related Product Information

• Efegatran
• N,N-DI-N-BUTYLETHYLENEDIAMINE
• 2-Amino-N-cyclohexylacetamide
• 1,2,3,4-Tetrahydroisoquinoline-3-carboxamide
• HOE 140
• 2-Aminoethyldiisopropylamine
• 1-ETHYL-3-PYRROLIDINOL
• HOE 140 SYNTHETIC >99% SELECTIVE B2 BRAD YKIN
• 1-METHYL-2-THIOPHEN-2-YL-ETHYLAMINE
• H-LEU-ARG-OH
• 3-(3,4-DIHYDROISOQUINOLIN-2(1H)-YL)PROPAN-1-OL
• CHEMBRDG-BB 9070704
• METHYL-(2-THIOPHEN-2-YL-ETHYL)-AMINE
• 1-(3,4-dihydroisoquinolin-2(1H)-yl)propan-2-amine
• (3R)-1-(2-AMINOETHYL)-3-PYRROLIDINOL
• N-(2-(BENZYLAMINO)ETHYL) CYCLOHEXANAMINE
• (R)-1,2,3,4-TETRAHYDRO-ISOQUINOLINE-3-CARBOXYLIC ACID AMIDE
• N-formylmethamphetamine